ARCHIVES

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

This article is from The Cancer Letter archive.

Vol. 29 No. 18 | May 2, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Plans Research To Reduce Cancer Disparities.

June 16, 2000

Stand Up To Cancer Awards 13 Grants

January 15, 2010

In Brief: Van Andel Institute to Build Epigenetics Hub

February 28, 2014

“Start Fighting” Says Former Rep. John Porter To Crowd of 12,000 at AACR Washington Rally

April 12, 2013

NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year

January 11, 1991

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013